<code id='8F8CC787A0'></code><style id='8F8CC787A0'></style>
    • <acronym id='8F8CC787A0'></acronym>
      <center id='8F8CC787A0'><center id='8F8CC787A0'><tfoot id='8F8CC787A0'></tfoot></center><abbr id='8F8CC787A0'><dir id='8F8CC787A0'><tfoot id='8F8CC787A0'></tfoot><noframes id='8F8CC787A0'>

    • <optgroup id='8F8CC787A0'><strike id='8F8CC787A0'><sup id='8F8CC787A0'></sup></strike><code id='8F8CC787A0'></code></optgroup>
        1. <b id='8F8CC787A0'><label id='8F8CC787A0'><select id='8F8CC787A0'><dt id='8F8CC787A0'><span id='8F8CC787A0'></span></dt></select></label></b><u id='8F8CC787A0'></u>
          <i id='8F8CC787A0'><strike id='8F8CC787A0'><tt id='8F8CC787A0'><pre id='8F8CC787A0'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:38477
          a man holds his vaccination reminder card and a "CVS Health" sticky note. -- health business coverage from STAT
          Wilfredo Lee/AP

          Medicare Advantage members continue to go to the doctor and get health care procedures a lot more than predicted, CVS Health executives said at the J.P. Morgan Healthcare Conference on Monday.

          A persistent theme for health insurance companies throughout 2023 has been their Medicare Advantage members using more care than their actuaries projected, which has been eating into the profits they get from federally funded health care premiums.

          advertisement

          CVS, a major seller of Medicare Advantage plans, has not yet closed the books on its 2023 finances. But CVS’ new CFO, Tom Cowhey, disclosed on Monday that costs for its Medicare Advantage members now “might exceed” their already-elevated guidance from November as the company sifts through fourth-quarter data.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          The Biogen Aduhelm mess could happen again
          The Biogen Aduhelm mess could happen again

          BiogenrecentlyannounceditwillceaseboththestudyandsaleofitsAlzheimer'sdrugAduhelm.JessicaRinaldi/TheB

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Readout Newsletter: Amgen, Regeneron, BGI Group and more

          KristofferTripplaar/SipaviaAPWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup toget